The treatment has the potential to prevent Aspergillus fungal infections in people who have had a lung transplant.
Site Search
The Institute for Clinical and Economic Review (ICER) developed an assessment of the comparative clinical effectiveness and value of cystic fibrosis therapies. The Foundation provided input to help inform this process.
As part of its Building Trust Video series, the Better Business Bureau's (BBB) Wise Giving Alliance is featuring an interview with Preston W. Campbell, III, M.D., president and CEO of the Cystic Fibrosis Foundation.
The European Commission has approved the use of the CF therapy Kalydeco™ for people with the G551D mutation ages 6 and older in the European Union.
In the largest forum of its kind, more than 4,000 doctors, scientists and caregivers from around the world are meeting today in Atlanta for the 28th annual North American Cystic Fibrosis Conference (NACFC).
An observation by surfers in Australia has led to a simple, inexpensive hypertonic saline therapy.
The Foundation seeks to advance its mission by making improvements in key areas of health equity and outcomes and diverse workforce development.
More than 200 advocates gathered on Capitol Hill during the Cystic Fibrosis Foundation's 14th Annual March on the Hill, championing antibiotic research and development and other policy needs on behalf of people with CF.